Imunon, Inc. (IMNN)
NASDAQ: IMNN · Real-Time Price · USD
6.84
-0.24 (-3.39%)
At close: Aug 12, 2025, 4:00 PM
6.88
+0.04 (0.58%)
Pre-market: Aug 13, 2025, 8:50 AM EDT
Imunon Employees
Imunon had 25 employees as of December 31, 2024. The number of employees decreased by 8 or -24.24% compared to the previous year.
Employees
25
Change (1Y)
-8
Growth (1Y)
-24.24%
Revenue / Employee
n/a
Profits / Employee
-$629,830
Market Cap
17.25M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 25 | -8 | -24.24% |
| Dec 31, 2023 | 33 | 2 | 6.45% |
| Dec 31, 2022 | 31 | 2 | 6.90% |
| Dec 31, 2021 | 29 | 2 | 7.41% |
| Dec 31, 2020 | 27 | -2 | -6.90% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
IMNN News
- 7 days ago - IMUNON Recaps Highlights from 2025 Second Quarter Financial Results Conference Call - GlobeNewsWire
- 7 days ago - Imunon, Inc. (IMNN) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - IMUNON Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 14 days ago - IMUNON Announces First Patient Dosed in Phase 3 OVATION 3 Study of IMNN-001 in Newly Diagnosed Advanced Ovarian Cancer - GlobeNewsWire
- 15 days ago - IMUNON to Hold Second Quarter 2025 Financial Results and Business Update Conference Call on Tuesday, August 5, 2025 - GlobeNewsWire
- 16 days ago - IMUNON Announces Stock Dividend Boosting Shareholder Value - GlobeNewsWire
- 21 days ago - IMUNON Announces Reverse Stock Split - GlobeNewsWire
- 4 weeks ago - IMUNON Granted Continued Listing Extension by Nasdaq to Complete Compliance Plan - GlobeNewsWire